Manchester, United Kingdom

Nicholas Billinton

This inventor holds 1 USPTO granted patent. Top assignee: Gentronix Limited. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nicholas Billinton

Introduction

Nicholas Billinton is a notable inventor based in Manchester, GB. He is recognized for his contributions to the field of biotechnology, particularly through his work on the green fluorescent protein. His innovative approach has led to significant advancements in various scientific applications.

Latest Patents

Nicholas Billinton holds a patent for the green fluorescent protein, which has become a vital tool in molecular biology. This invention has opened new avenues for research and has been widely adopted in laboratories around the world. He has 1 patent to his name, showcasing his ability to create impactful scientific solutions.

Career Highlights

Billinton is currently employed at Gentronix Limited, a company that specializes in genetic safety assessment and innovative biotechnology solutions. His role at Gentronix has allowed him to further develop his ideas and contribute to the company's mission of advancing genetic research.

Collaborations

Throughout his career, Nicholas has collaborated with esteemed colleagues, including Michael Gordon Barker and Nicholas John Goddard. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Nicholas Billinton's work exemplifies the spirit of innovation in biotechnology. His contributions, particularly in developing the green fluorescent protein, have made a lasting impact on scientific research. His career at Gentronix Limited and collaborations with other professionals highlight his commitment to advancing technology in his field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…